- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Processa Pharmaceuticals Inc (PCSA)
Assess today's live Processa Pharmaceuticals Inc (PCSA) share price, performance and insights using our live NASDAQ: PCSA stock exchange data.
Analyse the historical data and Processa Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Processa Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Processa Pharmaceuticals (PCSA) stock price today with other investors in the Processa Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PCSA share price (ISIN: US74275C4033) to enhance your trading decisions with our free investment tools and resources.
What Is the Processa Pharmaceuticals Inc Share Price Today?
The Processa Pharmaceuticals share price today is 2.3300.
What Is the Stock Symbol for Processa Pharmaceuticals Inc
The stock symbol (or 'ticker') for Processa Pharmaceuticals Inc is "PCSA."
What Stock Exchange Does Processa Pharmaceuticals Inc Trade On?
Processa Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Processa Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Processa Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Processa Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Processa Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Processa Pharmaceuticals (PCSA) stock price today with other investors in the Processa Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PCSA share price (ISIN: US74275C4033) to enhance your trading decisions with our free investment tools and resources.
What Is the Processa Pharmaceuticals Inc Share Price Today?
The Processa Pharmaceuticals share price today is 2.3300.
What Is the Stock Symbol for Processa Pharmaceuticals Inc
The stock symbol (or 'ticker') for Processa Pharmaceuticals Inc is "PCSA."
What Stock Exchange Does Processa Pharmaceuticals Inc Trade On?
Processa Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Processa Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Processa Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.1500
3.1700
52 wk Range
1.7600
19.6348
PCSA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.15003.1700
52 wk Range
1.760019.6348
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PCSA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
25.0000
Upside
+972.96%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells. Its oncology pipeline includes NGC-Cap (PCS6422), a combination of PCS6422 and capecitabine, which is in a Phase 2 clinical trial to treat metastatic breast, colorectal, hepatocellular, pancreatic, gastric, and other solid tumors; and NGC-Iri (PCS11T), an analog of an active metabolite of irinotecan, which is in preclinical trials to treat lung, pancreatic, ovarian, colorectal, gastric, cervical, and other cancers. The company also develops non-oncology drugs consisting of PCS499, an oral tablet of the deuterated analog of pentoxifylline that has completed a Phase 2b clinical trial for the treatment of primary glomerular diseases, including focal segmental glomerulosclerosis (FSGS), IgA, and membranous nephropathy, as well as ulcerative necrobiosis lipoidica; and PCS12852, a highly specific and potent 5HT4 agonist that has completed a Phase 2 clinical trial for the treatment of gastroparesis and constipation disorders. It has license agreements with Elion Oncology, Inc., Aposense, Ltd., Yuhan Corporation, and Sun Pharmaceuticals Industries Limited. Processa Pharmaceuticals, Inc. was founded in 2015 and is based in Vero Beach, Florida.
Compare PCSA to Peers and Sector
Metrics to compare | PCSA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPCSAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | 2.0x | −0.5x | |
PEG Ratio | −0.01 | 0.56 | 0.00 | |
Price/Book | 0.9x | 1.3x | 2.6x | |
Price / LTM Sales | - | 2.3x | 3.1x | |
Upside (Analyst Target) | - | 51.0% | 55.6% | |
Fair Value Upside | Unlock | 25.5% | 8.6% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 25.0000
(+972.96% Upside)
Earnings
Latest Release
06/11/2025
EPS / Forecast
-0.07 / -0.45
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Processa Pharmaceuticals (PCSA) Share Price Today?
The Processa Pharmaceuticals stock price today is 2.3300 USD.
What Stock Exchange Does Processa Pharmaceuticals (PCSA) Trade On?
Processa Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Processa Pharmaceuticals?
The stock symbol (also called a 'ticker') for Processa Pharmaceuticals is "PCSA."
What Is the Current Processa Pharmaceuticals Market Cap?
As of today, Processa Pharmaceuticals market cap is 5.2800M USD.
What Is Processa Pharmaceuticals's (PCSA) Earnings Per Share (TTM)?
The Processa Pharmaceuticals EPS is currently -10.3600 (Trailing Twelve Months).
Is PCSA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Processa Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Processa Pharmaceuticals Stock Split?
Processa Pharmaceuticals has split 4 times. (See the PCSA stock split history page for full effective split date and price information.)
How Many Employees Does Processa Pharmaceuticals Have?
Processa Pharmaceuticals has 10 employees.
What is the current trading status of Processa Pharmaceuticals (PCSA)?
As of 20/03/2026, Processa Pharmaceuticals (PCSA) is trading at a price of 2.3300 USD, with a previous close of 2.3300 USD. The stock has fluctuated within a day range of 2.1500 USD to 3.1700 USD, while its 52-week range spans from 1.7600 USD to 19.6348 USD.
What Is Processa Pharmaceuticals (PCSA) Price Target According to Analysts?
The average 12-month price target for Processa Pharmaceuticals is 25.0000 USD, with a high estimate of 25 USD and a low estimate of 25 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +972.96% Upside potential.
What Is the PCSA Premarket Price?
PCSA's last pre-market stock price is 2.3500 USD. The pre-market share volume is 900.0000, and the stock has decreased by 0.0200, or 0.8600%.
What Is the PCSA After Hours Price?
PCSA's last after hours stock price is 2.2800 USD, the stock has decreased by -0.0500, or -2.1500%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.